Literature DB >> 11038080

Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies.

N Namias1, L Samiian, D Nino, E Shirazi, K O'Neill, D H Kett, E Ginzburg, M G McKenney, D Sleeman, S M Cohn.   

Abstract

BACKGROUND: The purpose of this study was to determine whether the incidence of recovery and patterns of antibiotic susceptibility of pathogenic bacteria vary between intensive care units (ICUs) in a single teaching hospital.
METHODS: Culture and susceptibility results were collected prospectively for a 3-month period (April through June 1999) in each of the surgical, trauma, and medical ICUs. The number of unique isolates and susceptibility patterns were determined. Susceptibility of isolates among ICUs was compared with chi2.
RESULTS: Statistically significant differences between ICUs in susceptibility to various antibiotics were found for Staphylococcus aureus, Enterococcus sp, Acinetobacter sp, Enterobacter sp, Klebsiella sp, and Pseudomonas sp. Notably, vancomycin-resistant Enterococcus was not seen in the medical ICU, whereas it was seen in both the surgical and trauma ICUs. Klebsiella spp resistant to ceftazidime were seen only in the trauma ICU. The aminoglycosides and quinolones had attenuated activity against Pseudomonas sp in the surgical ICU, whereas they remained highly effective in the trauma ICU. Cefazolin had no activity against the Enterobacter sp in either of the surgical ICUs, but was highly effective in the medical ICU.
CONCLUSION: Although the microbiologic results of this study should not be extrapolated to other institutions, the principle is of value. There is variability between ICUs in a single large teaching hospital in susceptibility of bacterial pathogens to various antibiotics. This may have implications in the design of empiric antibiotic strategies and the planning of the hospital formulary. Hospital wide or composite ICU antibiograms are inadequate for planning empiric therapy in the ICU.

Entities:  

Mesh:

Year:  2000        PMID: 11038080     DOI: 10.1097/00005373-200010000-00010

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  13 in total

Review 1.  Appropriate antibiotic therapy for ventilator-associated pneumonia and sepsis: a necessity, not an issue for debate.

Authors:  Marin H Kolleff
Journal:  Intensive Care Med       Date:  2003-02       Impact factor: 17.440

2.  Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital- and community-acquired infection.

Authors:  F Lamoth; A Wenger; G Prod'hom; Y Vallet; C Plüss-Suard; J Bille; G Zanetti
Journal:  Infection       Date:  2010-06-16       Impact factor: 3.553

3.  Antimicrobial susceptibilities of respiratory pathogens in the surgical/trauma intensive care unit compared with the hospital-wide respiratory antibiogram in a level I trauma center.

Authors:  Sara Al-Dahir; Christopher Gillard; Fatima Brakta; Julio E Figueroa
Journal:  Surg Infect (Larchmt)       Date:  2015-02       Impact factor: 2.150

4.  Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors.

Authors:  Ignacio Martin-Loeches; Maria Deja; Despoina Koulenti; George Dimopoulos; Brian Marsh; Antonio Torres; Michael S Niederman; Jordi Rello
Journal:  Intensive Care Med       Date:  2013-01-29       Impact factor: 17.440

Review 5.  Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy".

Authors:  Alberto Sandiumenge; Emili Diaz; Maria Bodí; Jordi Rello
Journal:  Intensive Care Med       Date:  2003-04-02       Impact factor: 17.440

6.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors:  Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

Review 7.  Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time.

Authors:  Marin Kollef
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 9.  Acinetobacter infections: a growing threat for critically ill patients.

Authors:  M E Falagas; E A Karveli; I I Siempos; K Z Vardakas
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

10.  A 2000 patient retrospective assessment of a new strategy for burn wound management in view of infection prevention and treatment.

Authors:  Justyna Glik; Wojciech Łabuś; Diana Kitala; Karolina Mikuś-Zagórska; Christopher D Roberts; Mariusz Nowak; Aleksandra Kasperczyk; Marek Kawecki
Journal:  Int Wound J       Date:  2017-12-15       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.